Category: Trading
EUR/USD slips under 1.1800 on strong PMI data, Fed bets...
EUR/USD drops for the second straight day down 0.49%, following last Friday’s metals rout which underpinned the Greenback to the d...
China: Economic outlook under pressure – Commerzbank
Commerzbank's Economic Research report highlights the ongoing struggles of the Chinese economy, with both the manufacturing and se...
Pound Sterling losses slow as BoE rate decision looms
• GBP/USD eased to 1.3646 on Monday, retreating from the August 2021 high of 1.3847 touched last week as markets position ahead of...
RBA expected to hike interest rates in February amid re...
The Reserve Bank of Australia (RBA) is widely expected to raise the Official Cash Rate (OCR) to 3.85% from 3.6% after concluding i...
South Korea Consumer Price Index Growth (MoM) in line w...
South Korea Consumer Price Index Growth (MoM) in line with expectations (0.4%) in January
MYR: Forecasts lowered amid strong performance – DBS
DBS Bank's Group Research report, authored by Philip Wee, has lowered its forecasts for the MYR, reflecting its strong performance...
South Korea Consumer Price Index Growth (YoY) registere...
South Korea Consumer Price Index Growth (YoY) registered at 2%, below expectations (2.1%) in January
USD/JPY gathers strength above 155.50 as upbeat US data...
The USD/JPY pair attracts some buyers to around 155.55 during the early Asian session on Tuesday. The upbeat US economic data prov...
NZD/USD consolidates below seven-month highs ahead of k...
• NZD/USD eased to 0.6008 on Monday, pulling back from seven-month highs near 0.6045 as the Kiwi consolidates strong January gains...
Trump’s plan to make housing affordable is faltering
“We’re not going to destroy the value of their homes so somebody who didn’t work very hard can buy a home,” Trump said.
Silicon Valley legend Kleiner Perkins was written off. ...
For the first time in eight years, Kleiner Perkins opened its doors to a reporter. Fortune gets an exclusive look inside the legen...
How Pfizer’s CEO wielded moral clarity to help his team...
The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.
